X

Drug Utilization & Outcomes (DUO) Community

The Drug Utilization & Outcomes (DUO) Community brings together researchers from different disciplines who are interested in all aspects of research related to the safety, effectiveness, and utilization of therapeutics, as well as health outcomes, comparative effectiveness research, benefit-risk, risk management/mitigation, and pharmacoeconomics. 

Community Goals
The goal of the DUO Community is to promote collaboration among researchers and to facilitate integration of knowledge across different disciplines and over the medical product life-cycle to ultimately inform decisions on high quality, cost-effective, and patient-centered health care. The DUO Community provides opportunities to:
  • Discuss and exchange ideas among Community members.
  • Educate clinical pharmacologists on health outcomes, comparative effectiveness, and pharmacoeconomics topics.
  • Present examples of integrating safety, effectiveness, utilization, comparative effectiveness, health outcomes, and pharmacoeconomics knowledge to inform drug development and health care decisions.
  • Support Community/Network proposals for abstracts, workshops, symposia, and pre-conferences.
  • Promote collaboration with other key scientific stakeholders sharing similar goals.
ASCPT 2019 Annual Meeting
Drug Utilization & Outcomes Community Hosted Lunch Table
Friday, March 15 (12:00 pm - 1:00 pm)
Washington 2-6
Grab your lunch and join ASCPT Network, Community and Journal leaders for small group, informal networking discussions over the lunch break. Learn more about ASCPT initiatives, the Family of Journals, 2020 planning, how you can become more involved in the Society, and much more!

Webinar ideas?
If you have a topic you would like to learn more about or to present, we encourage you to submit your input via the Webinar Proposal Submission portal.

Joshua J. Gagne, PharmD, ScD

Community Chair

 

Jing Liu, PhD

Community Vice Chair

 

Geert W. t'Jong, MD, PhD

Community Past Chair

 

Photo Gallery
Recent News
Contact Us